STARLIGHT THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 03 Dec 2025)
What this means for you
Not registered yet, but its 11 Feb 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97790983
- Mark type
- Stylized text
- Filed
- 11 Feb 2023
- Published for opposition
- 08 Apr 2025
- Attorney of record
- NIGAMNARAYAN ACHARYA
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development services in the field of oncology, namely, neuro and central nervous system oncology; pharmaceutical drug discovery services in the field of oncology; scientific and medical research and development for pharmaceuticals, pharmaceutical preparations and substances in the field of oncology, namely, neuro and central nervous system oncology
Owner
- STARLIGHT THERAPEUTICS INC., Dallas, TX, US
- STARLIGHT THERAPEUTICS INC., Dallas, TX, US
Prosecution history
- 04 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 03 Dec 2025 — SOU EXTENSION 1 GRANTED
- 03 Dec 2025 — SOU EXTENSION 1 FILED
- 03 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Jun 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 08 Apr 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 08 Apr 2025 — PUBLISHED FOR OPPOSITION
- 02 Apr 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 13 Mar 2025 — EXPARTE APPEAL TERMINATED
- 13 Mar 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Feb 2025 — EX PARTE APPEAL-INSTITUTED
- 11 Feb 2025 — JURISDICTION RESTORED TO EXAMINING ATTORNEY
- 06 Feb 2025 — NOTICE OF REVIVAL - E-MAILED
- 06 Feb 2025 — PETITION GRANTED - TTAB APPEAL FILED
- 04 Feb 2025 — ASSIGNED TO PETITION STAFF